Lanean...
The Minority Report: Targeting the Rare Oncogenes in NSCLC
Lung cancer is still responsible for the highest number of cancer deaths worldwide. Despite this fact, significant progress has been made in the treatment of non-small cell lung cancer (NSCLC). Specifically, efforts to identify and treat genetic alterations (gene mutations, gene fusions, gene amplif...
Gorde:
| Argitaratua izan da: | Curr Treat Options Oncol |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2014
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4216615/ https://ncbi.nlm.nih.gov/pubmed/25228144 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11864-014-0310-8 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|